Trends in paediatric antiseizure-medication use and costs in France, 2014–2023: a nationwide population-based analysis

Key Points

• Cost analysis shows significant variations in paediatric antiseizure medication expenses over the examined period.
• The average cost per child increased by 15% from 2014 to 2023, reflecting rising prescription rates of antiseizure medications.
• Population-based evaluation included healthcare data from diverse regions in France, indicating regional disparities in medication use.
• Findings highlight the necessity for ongoing monitoring of medication costs and prescribing practices to optimize treatment.